The PredictAD project: Development of novel biomarkers and analysis software for early diagnosis of the Alzheimer's disease

Interface Focus

Volumn 3, Issue 2, 2013, Pages

  Antila, Kari ^a   Lötjönen, Jyrki ^a   Thurfjell, Lennart ^b   Laine, Jarmo ^c   Massimini, Marcello ^d   Rueckert, Daniel ^e   Zubarev, Roman A ^f   Orešič, Matej ^a   van Gils, Mark ^a   Mattila, Jussi ^a   Simonsen, Anja Hviid ^g   Waldemar, Gunhild ^g   Soininen, Hilkka ^h  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b GE HEALTHCARE   (United Kingdom)

^c Nexstim Oy   (Finland)

^d UNIVERSITY OF MILAN   (Italy)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f KAROLINSKA INSTITUTE   (Sweden)

^g Rigshospitalet   (Denmark)

^h UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alzheimer's disease; Clinical decision support systems; Early diagnosis

Indexed keywords

EID: 84875437012     PISSN: 20428898     EISSN: 20428901     Source Type: Journal    
DOI: 10.1098/rsfs.2012.0072     Document Type: Article

References (26)

1. Wimo A, Prince M. 2010 World Alzheimer Report 2010: the global economic impact of dementia. London, UK: ADI. See http://www.alz.co.uk/research/files/ WorldAlzheimerReport2010ExecutiveSummary.pdf.
2. Carone G, Costello D. 2006 Can Europe afford to grow old? Finance Dev. 43, 8-31. See http://www. imf.org/external/pubs/ft/fandd/2006/09/carone.htm.
3. Bond J, Stave C, Sganga A, Vincenzino O, O'connell B, Stanley RL. 2005 Inequalities in dementia care across Europe: key findings of the Facing Dementia Survey. Int. J. Clin. Practice 59, 8-14. (doi:10.1111/ j.1368-504X.2005.00480.x)
4. Dubois B et al. 2007 Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 8, 734-746. (doi:10.1016/S1474-4422(07)70178-3)
5. McKhann GM et al. 2011 The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 263-269. (doi:10.1016/j.jalz.2011.03.005)
6. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. 2007 Recommendations for the diagnosis and management of Alzheimer's disease and other disorders asscociated with dementia: EFNS guideline. Eur. J. Neurol. 14, e1-e26. (doi:10.1111/ j.1468-1331.2006.01605.x)
7. Orešič M et al. 2011 Metabolome in progression to Alzheimer's disease. Transl. Psychiatry 1, e57. (doi:10.1038/tp.2011.55)
8. Yang H, Lyutvinskiy Y, Soininen H, Zubarev RA. 2011 Alzheimer's disease and mild cognitive impairment are associated with elevated levels of isoaspartyl residues in blood plasma proteins. J. Alzheimer's Dis. 27, 113-118. (doi:10.3233/JAD-2011-110626)
9. Casarotto S et al. 2011 TMS-evoked potentials in physiological and pathological aging. Neuroreport 22, 592-597. (doi:10.1097/WNR.0b013e3283 49433a)
10. Niskanen E et al. 2011 New insights into Alzheimer's disease progression: a combined TMS and structural MRI study. PloS ONE 6, e26113. (doi:10.1371/journal.pone.0026113)
11. Soininen H, Liu Y, Rueckert D, Lötjönen J. 2012 Hippocampal atrophy in Alzheimer's disease. Neurodegener. Dis. Manage. 2, 197-209. (doi:10. 2217/nmt.12.13)
12. Lötjönen J et al. 2011 Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease. NeuroImage 56, 185-196. (doi:10.1016/j.neuroimage.2011.01.062)
13. Wolz R, Heckemann R, Aljabar P, Hajnal JV, Lotjonen J, Rueckert D, Alzheimer's Disease Neuroimgaging Intiative. 2012 Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI. NeuroImage 52, 109-118. (doi:10.1016/j.neuroimage.2010.04.006)
14. Koikkalainen J, Lötjönen J, Thurfjell L, Rueckert D, Waldemar G, Soininen H, Alzheimer's Disease Neuroimgaging Intiative. 2011 Multi-Template tensor-based morphometry: application to analysis of Alzheimer's disease. NeuroImage 56, 1134-1144. (doi:10.1016/j.neuroimage. 2011.03.029)
15. Wolz R, Aljabar P, Hajnal JV, Lotjonen J, Rueckert D, Alzheimer's Disease Neuroimgaging Intiative. 2012 Nonlinear dimensionality reduction combining mr imaging with non-imaging information. Med. Image Anal. 16, 819-830. (doi:10.1016/j.media. 2011.12.003)
16. Gray KR, Wolz R, Heckemann R, Rueckert D, Alzheimer's Disease Neuroimgaging Intiative. 2012 Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease. NeuroImage 60, 221-229. (doi:10.1016/j. neuroimage.2011.12.071)
17. Thurfjell L, Lötjönen J, Lundqvist R, Koikkalainen J, Soininen H, Waldemar G, Vandenberghe R. 2012 Combination of biomarkers from PET [18F]flutemetamol amyloid imaging and structural MRI in dementia. Neurodegener. Dis. 10, 246-249. (doi:10.1159/000335381)
18. Mattila J, Koikkalainen J, Virkki A, Simonsen A, van Gils M, Waldemar G, Soininen H, Lotjonen J, Alzheimer's Disease Neuroimgaging Intiative. 2011 Disease state fingerprint for evaluating the state of Alzheimer's disease in patients. J. Alzheimer's Dis. 27, 163-176. (doi:10.3233/JAD-2011-110365)
19. Wolz R, Julkunen J, Koikkalainen J, Eini N, Dong PZ. 2011 Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease. PLoS ONE 6, e25446. (doi:10.1371/journal.pone.0025446)
20. Hviid-Simonsen A et al. 2011 Application of the PredictAD software tool to the differentiation between stable and progressive MCI. EFNS 7, S169. (doi:10.1016/j.jalz.2011.05.457)
21. Soininen H, Mattila J, Koikkalainen J, van Gils M, Hviid Simonsen A, Waldemar G, Rueckert D, Thurfjell L, Lötjönen J. 2012 Software tool for improved prediction of Alzheimer's disease. Neurodegener. Dis. 10, 149-152. (doi:10.1159/ 000332600)
22. Mattila J, Soininen H, Koikkalainen J, Rueckert D, Wolz R, Waldemar G, Lötjönen J. 2012 Optimizing the diagnosis of early Alzheimer's disease in mild cognitive impairment subjects. J. Alzheimer's Dis. 32, 969-979. (doi:10.3233/JAD-2012-120934)
23. Fan Y, Resnick SM, Wua X. 2008 Structural and functional biomarkers of prodromal Alzheimer's disease: a high-dimensional pattern classification study. NeuroImage 41, 277-285. (doi:10.1016/j. neuroimage.2008.02.043)
24. Fonteijn HM et al. 2012 An event-based model for disease progression and its application in familial Alzheimer's disease and Huntington's disease. NeuroImage 60, 1597-1924. (doi:10.1016/j. neuroimage.2012.01.106)
25. Jack CR et al. 2010 Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128. (doi:10.1016/S1474-4422(09)70299-6)
26. Jedynak BM et al. 2012 A computational neurodegenerative disease progression score: method and results with the Alzheimer's disease neuroimaging initiative cohort. NeuroImage 63, 1478-1486. (doi:10.1016/j.neuroimage. 2012.07.059)